Sabine Heitzeneder
0000-0001-8770-2192
Publication & Citation Trends
Publications
0 total
Abstract 4009: Decoding the medulloblastoma surfaceome prioritizes the oncofetal antigen GPC2 for potent CAR-T cell therapy
Cited by 0
Semantic Scholar
Metabolic vulnerability is a target of the antineoplastic effect of breastfeeding
Cited by 0
Semantic Scholar
Abstract 6463: Longitudinal single-cell atlas of GD2-CAR T cell therapy in H3K27M-mutant diffuse midline glioma identifies humoral and cellular anti-CAR immunity
Cited by 0
Semantic Scholar
c-JUN enhances CRISPR knockin anti-B7-H3 CAR T cell function in small cell lung cancer and thoracic SMARCA4-deficient undifferentiated tumors
Cited by 1
Semantic Scholar
CTIM-05. HUMANIZED ANTI-CAR ANTIBODIES AFFECT DURABLE RESPONSE TO GD2-CAR T-CELLS IN DIFFUSE MIDLINE GLIOMA
Cited by 0
Semantic Scholar
269 Humanized anti-CAR antibodies affect durable response to GD2-CAR T-cells in diffuse midline glioma
Cited by 0
Semantic Scholar
EXTH-142. Quantitative surfaceome profiling of high-risk medulloblastoma prioritizes the oncofetal antigen GPC2 for potent CAR-T cell therapy
Cited by 0
Semantic Scholar
Abstract 6116: Generation of multi-specific CAR T cells using a novel single-marker selection platform to target medulloblastoma heterogeneity
Cited by 0
Semantic Scholar
Engineered CD47 protects T cells for enhanced antitumour immunity OA
Cited by 90
Semantic Scholar
Research Topics
CAR-T cell therapy research
(34)
Immunotherapy and Immune Responses
(11)
Neuroblastoma Research and Treatments
(10)
Cancer Immunotherapy and Biomarkers
(7)
Virus-based gene therapy research
(7)
Affiliations
National Institutes of Health
Cancer Prevention Institute of California
Palo Alto University
St Anna Children's Hospital
Stanford Medicine